2Johnston SC,Higashida RT,Barrow DL,et al.Recommendations for the endovascular treatment of intracranial aneurysms:a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology.Stroke,2002,33(10):2536-2544.
4International Study of Unruptured Intracranial Aneurysms investigators.Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention.N Engl J Med,1998,339:1725-1733.
5Brilstra EH,Rinkel GJ.Treatment of Ruptured Intracranial Aneurysms By Embolization With Controlled Detachable Coils.Neurologist,2002,8(1):35-40.
6Juvela S.Treatment options of unruptured intracranial aneurysms.Stroke,2004,35(2):372-374.
7Bendok BR,Hanel RA,Hopkins LN.Coil embolization of intracranial aneurysms.Neurosurgery,2003,52(5):1125-1130.
9Benitez RP,Silva MT,Klem J,et al.Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils.Neurosurgery,2004,54(6):1359-1367.
10Murayama Y,Tateshima S,Gonzalez NR,et al.Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms:long-term experimental study.Stroke,2003,34(8):2031-2037.
二级参考文献30
1Clarke TA,Waskell LA.The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin[J].Drug Metab Dispos,2003,31(1):53-59.
2Wienbergen H,Gitt AK,Schiele R,et al.Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies[J].Am J Cardiol,2003,92(3):285-288.
3Serebruany VL,Midei MG,Malinin AI,et al.Atorvastatin does not affect the antiplatelet properties of clopidogrel in patients undergoing coronary stenting in randomized data from the interaction of atorvastatin and clopidogrel trial[J].J Am Coll Cardiol,2003,41(2):302A.
4Mitsios JV,Papathanasiou AP,Rodis FI,et al.Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes[J].Circulation,2004,109(11):1335-1338.
5Saw J,Steinhubl SR,Berger PB,et al.Clopidogrel for the reduction of events during observation investigators.Lack of adverse clopidogrel- atorvastatin clinical interaction from secondary analysis of a randomized,placebo-controlled clopidogrel trial[J].Circulation,2003,108(9):921-924.
6Havranek EP,Weinberger J.Concomitant use of angiotensin-converting enzyme(ACE)inhibitors and antiplatelet therapies:clopidogrel versus aspirin[J].J Hypertens,1999,17:S57.
7Lale A,Herbert JM,Savi P.The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine[J].Thromb Haemost,2003,90(5):839-843.
8Muller I,Seyfarth M,Rudiger S,et al.Effect of a high dose of clopidogrel on platelet function in patients undergoing coronary stent placement[J].Heart,2001,85(1):92-93.
9O'Naill WW,Serruys P,Knudtson M,et al.Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularisation[J].N Engl J Med,2000,342(17):1316-1324.
10The 2nd SYMPHONY Investigators.Randomized trial of aspirin,sibrafiban,or both for secondary prevention after acute coronary syndromes[J].Circulation,2001,103(13):1727-1733.
7Sharma BS,Sinha S,Mehta VS,et al.Pediatric intraeranial aneurysmsclinical characteristics and outcome of surgical treatment.Childs Nerv Syst,2007,23:327-333.
8Huang J,McGirt M J,Gailloud P,et al.lntracranial aneurysms in the pediatric population:case series and literature review.Surg Neurol,2005,63:424-433.
9Ventureyra EC.Pediatric intracranial aneurysms:a different perspective.J Neuresurg,2006,104:79-81.
